
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals